1
TITLE: Antiepileptogenesis after stroke-trials and tribulations: Methodological challenges and recruitment results of a Phase II study with eslicarbazepine acetate
AUTHORS: Koepp, Matthias J. J.; Trinka, Eugen; Mah, Yee Haur; Bentes, Carla; Knake, Susanne; Gigli, Gian Luigi; Serratosa, Jose M.; Zelano, Johan; Magalhaes, Luis M.; Pereira, Ana; Moreira, Joana; Soares da Silva, Patricio;
PUBLISHED: 2023, SOURCE: EPILEPSIA OPEN
INDEXED IN: Scopus WOS
2
TITLE: Design of a double-blind, randomized, phase II trial in the prevention of epilepsy in stroke: anti-epileptogenic effects of eslicarbazepine acetate  Full Text
AUTHORS: Koepp, M; Trinka, E; Moreira, J; Ikedo, F; Pereira, A; Guimaraes, B; Gama, H; Soares da Silva, P;
PUBLISHED: 2021, SOURCE: EPILEPSIA, VOLUME: 62
INDEXED IN: WOS
3
TITLE: A European questionnaire survey on epilepsy monitoring units' current practice for postoperative psychogenic nonepileptic seizures' detection  Full Text
AUTHORS: Sofia Markoula; Andreas Liampas; Guido Rubboli; John Duncan; Demetrios N Velis; Andreas Schulze Bonhage; Alla Guekht; Karen Bartholomeyczik; Jane de Tisi; Adrien Gras; Morten Ingvar Lossius; Flavio Villani; Anke Maren Staack; Annette Hospes; Johannes C Baaijen; Elisabeth C W van Straaten; Hanneke E Ronner; Sara Casciato; Alfredo D'Aniello; Addolorata Mascia; Susana Ferrao Santos; Carla Bentes; Angel Aledo Serrano; Antonio Gil Nagel; Petia Dimova; Hrvoje Hecimovic; Cigdem Ozkara; Kristina Malmgren; Savvas Papacostas; Anna Kelemen; Markus Reuber; Eugen Trinka; Philippe Ryvlin; ...More
PUBLISHED: 2020, SOURCE: EPILEPSY & BEHAVIOR, VOLUME: 112
INDEXED IN: Scopus WOS
4
TITLE: Long-term efficacy and safety of eslicarbazepine acetate (ESL) monotherapy: results from BIA-2093-311/EXT study -the 2-year open-label extension of the ESL study (BIA-2093-311)
AUTHORS: Eugen Trinka; Ana Pereira; Joana Moreira; Luis Magalhaes; Fabio Ikedo; Helena Gama;
PUBLISHED: 2020, SOURCE: Annual Meeting of the American-Academy-of-Neurology in NEUROLOGY, VOLUME: 94, ISSUE: 15
INDEXED IN: WOS
5
TITLE: Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study  Full Text
AUTHORS: Eugen Trinka; Rodrigo Rocamora; Joao Chaves; Joana Moreira; Fabio Ikedo; Patricio Soares da Silva;
PUBLISHED: 2020, SOURCE: EPILEPSIA
INDEXED IN: WOS
6
TITLE: Serum sodium levels and related treatment-emergent adverse events during eslicarbazepine acetate use in adults with epilepsy  Full Text
AUTHORS: Robert T Wechsler; Rodney A Radtke; Michael Smith; David G Vossler; Laura Strome; Eugen Trinka; Ilailong L Cheng; Todd Grinnell; David Blum; Mariana Vieira; Joana Moreira; Francisco Rocha;
PUBLISHED: 2019, SOURCE: EPILEPSIA, VOLUME: 60, ISSUE: 7
INDEXED IN: Scopus WOS
7
TITLE: Influence of of titration schedule and maintenance dose on the tolerability of adjunctive eslicarbazepine acetate: An integrated analysis of three randomized placebo-controlled trials  Full Text
AUTHORS: Gregory Krauss; Victor Biton; Jay H Harvey; Christian Elger; Eugen Trinka; Patricio Soares da Silva; Helena Gama; Hailong L Cheng; Todd Grinnell; David Blum;
PUBLISHED: 2018, SOURCE: EPILEPSY RESEARCH, VOLUME: 139
INDEXED IN: Scopus WOS
10
TITLE: Sodium and Thyroid Hormone Levels During Phase III Trials of Adjunctive Eslicarbazepine Acetate (ESL), According to Concomitant Antiepileptic Drug (AED) Use
AUTHORS: Eugen Trinka; Meriem Bensalem Owen; Todd Grinnell; David Cantu; Joana Graca; Joana Moreira; Hailong L Cheng; David Blum;
PUBLISHED: 2018, SOURCE: 70th Annual Meeting of the American-Academy-of-Neurology (AAN) in NEUROLOGY, VOLUME: 90
INDEXED IN: WOS
Page 1 of 2. Total results: 19.